A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Kidney Transplantation
Interventions
DRUG

ASP8597

one time IV dose

DRUG

Placebo

one time IV dose

Trial Locations (19)

10065

New York Presbyterian Hospital, New York

10467

Montefiore Medical Center, The Bronx

17011

Pinnacle Health at Harrisburg, Harrisburg

22908

University of Virginia, Charlottesville

27710

Duke University, Durham

27834

East Carolina University, Greenville

28203

Carolinas Medical Center, Charlotte

48109

University of Michigan, Ann Arbor

53792

University of Wisconsin, Madison

63110

Washington University, St Louis

75246

Baylor University Medical Center, Dallas

76104

Baylor All Saints Medical Center, Fort Worth

77030

The Methodist Hospital, Houston

80045

University of Colorado, Aurora

90057

St. Vincent Medical Center, Los Angeles

92123

Sharp Memorial, San Diego

94115

California Pacific Medical Center, San Francisco

94143

University of California at San Francisco, San Francisco

07039

St. Barnabas Medical Center, Livingston

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY